电邮这篇文章 Oncolytic Activity of the Vaccine Strain of Type 3 Poliovirus on the Model of Rat Glioma C6 Cells
- 作者: Sosnovtseva A.O.1,2, Zheltukhin A.O.2, Lipatova A.V.2, Chumakov P.M.2,3, Chekhonin V.P.1,4
-
隶属关系:
- V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation
- V. A. Engelhardt Institute of Molecular Biology, Russian Academy of Science
- M. P. Chumakov Federal Research Center for Research and Development of Immunobiological Products, Russian Academy of Sciences
- N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
- 期: 卷 167, 编号 1 (2019)
- 页面: 111-115
- 栏目: Methods
- URL: https://journals.rcsi.science/0007-4888/article/view/241494
- DOI: https://doi.org/10.1007/s10517-019-04472-6
- ID: 241494
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
Rat glioma cell line C6 expressing human poliovirus receptor (PVR) and susceptible to polioviruses (C6-PVR-BFP) was used to produce a clone with knockout of IFNα/β (Ifnar1) receptor subunit 1 gene (Ifnar1). The sensitivity of C6-PVR-BFP cells to the vaccine strain of poliovirus type 3 (PV3) depended on the signaling pathways of the cell response to type 1 IFN. Using the model of subcutaneous tumor xenografts, we demonstrated oncolytic activity of PV3 against C6-PVR-BFP cells that depended on the expression of PVR and increased considerably upon disturbances in IFN response pathways.
作者简介
A. Sosnovtseva
V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation; V. A. Engelhardt Institute of Molecular Biology, Russian Academy of Science
编辑信件的主要联系方式.
Email: aososnovtceva@gmail.com
俄罗斯联邦, Moscow; Moscow
A. Zheltukhin
V. A. Engelhardt Institute of Molecular Biology, Russian Academy of Science
Email: aososnovtceva@gmail.com
俄罗斯联邦, Moscow
A. Lipatova
V. A. Engelhardt Institute of Molecular Biology, Russian Academy of Science
Email: aososnovtceva@gmail.com
俄罗斯联邦, Moscow
P. Chumakov
V. A. Engelhardt Institute of Molecular Biology, Russian Academy of Science; M. P. Chumakov Federal Research Center for Research and Development of Immunobiological Products, Russian Academy of Sciences
Email: aososnovtceva@gmail.com
俄罗斯联邦, Moscow; Moscow
V. Chekhonin
V. P. Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation; N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: aososnovtceva@gmail.com
俄罗斯联邦, Moscow; Moscow
补充文件
